Genesis Healthcare Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Genesis Healthcare.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Healthcare earnings growth | 17.1% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2021 | 3,462 | -22 | -255 | -206 | 1 |
12/31/2020 | 3,906 | -59 | 53 | 316 | N/A |
9/30/2020 | 4,123 | -63 | -7 | 258 | N/A |
6/30/2020 | 4,308 | 46 | -110 | 297 | N/A |
3/31/2020 | 4,496 | 63 | -413 | -4 | N/A |
12/31/2019 | 4,566 | 15 | -662 | -7 | N/A |
9/30/2019 | 4,616 | -43 | -628 | 20 | N/A |
6/30/2019 | 4,710 | -147 | -270 | 43 | N/A |
3/31/2019 | 4,837 | -182 | -274 | 37 | N/A |
12/31/2018 | 4,977 | -235 | -33 | 19 | N/A |
9/30/2018 | 5,119 | -256 | 10 | 67 | N/A |
6/30/2018 | 5,217 | -571 | 5 | 63 | N/A |
3/31/2018 | 5,286 | -597 | 8 | 70 | N/A |
12/31/2017 | 5,374 | -579 | 56 | 120 | N/A |
9/30/2017 | 5,423 | -467 | 30 | 100 | N/A |
6/30/2017 | 5,501 | -114 | 35 | 114 | N/A |
3/31/2017 | 5,568 | -72 | 2 | 89 | N/A |
12/31/2016 | 5,625 | -64 | -25 | 68 | N/A |
9/30/2016 | 5,657 | -352 | -31 | 49 | N/A |
6/30/2016 | 5,656 | -361 | -47 | 40 | N/A |
3/31/2016 | 5,645 | -355 | -60 | 36 | N/A |
12/31/2015 | 5,519 | -425 | -77 | 9 | N/A |
9/30/2015 | 5,278 | -283 | -79 | 17 | N/A |
6/30/2015 | 5,056 | -298 | -16 | 64 | N/A |
3/31/2015 | 4,842 | -312 | 26 | 92 | N/A |
12/31/2014 | 4,690 | -240 | 35 | 108 | N/A |
9/30/2014 | 4,641 | -170 | N/A | 153 | N/A |
12/31/2013 | 4,640 | -171 | N/A | 82 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if GENN's forecast earnings growth is above the savings rate (2.4%).
Earnings vs Market: Insufficient data to determine if GENN's earnings are forecast to grow faster than the US market
High Growth Earnings: Insufficient data to determine if GENN's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if GENN's revenue is forecast to grow faster than the US market.
High Growth Revenue: Insufficient data to determine if GENN's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if GENN's Return on Equity is forecast to be high in 3 years time